Brugia malayi
Scientific classification 
Kingdom: Animalia 
Phylum: Nematoda 
Class: Secernentea 
Order: Spirurida 
Family: Filariidae 
Genus: Brugia 
Species: B. malayi
Brugia malayi 
• is a roundworm nematode, one of the three 
causative agents of lymphatic filariasis in 
humans. 
• Lymphatic filariasis, also known as elephantiasis, 
is a condition characterized by swelling of the 
lower limbs. 
• The two other filarial causes of lymphatic 
filariasis areWuchereria bancrofti and Brugia 
timori, which differ from Brugia 
malayi morphologically, symptomatically, and in 
geographical extent
Geographical distribution 
• B. malayi infects 13 million people in south and 
southeast Asia and is responsible for nearly 10% 
of the world’s total cases of lymphatic filariasis 
• B. malayi infection is endemic or potentially 
endemic in 16 countries, where it is most 
common in southern China and India, but also 
occurs in Indonesia, Thailand, Vietnam, 
Malaysia, the Philippines, and South Korea
Morphology 
• Female adult worms measures between 
43-55 mm in length by 130-170 um in 
width. 
• Male adult worms measures between 13- 
23 mm in length by 70-80 um in width.
Microfilariae 
• B. malayi microfilariae measures 177-230 um 
in length and 5-7 um in width and have a 
round anterior end and a pointed posterior 
end. 
• The sheath is actually the egg shell, a thin layer 
that surrounds the egg shell as the 
microfilariae circulates in the bloodstream. 
• The microfilariae retain the sheath until it is 
digested in the mosquito midgut
Adult 
Sections of adult Brugia sp. From a lymph node, stained with hematoxylin and eosin. 
Microfilariae 
Posterior end of B. malayi microfilariae – 
note the two distinctive terminal nuclei
Life Cycle 
• The typical vector for Brugia malayi filariasis 
are mosquito species from genera Mansonia 
and Aedes.
Life cycle
Symptoms 
• Asymptomatic Phase: Upon initial 
infection no symptoms may be present 
as microfilariae mature. 
• B. Malayi is one of the causative agents 
of lymphatic filariasis, a condition 
marked by infection and swelling of the 
lymphatic system. 
• The disease is primarily caused by the 
presence of worms in the lymphatic 
vessels and the resulting host response.
• Signs of infection are typically 
consistent with those seen in 
bancroftian filariasis – fever, 
lymphadenitis, lymphangitis, 
lymphedema, and secondary bacterial 
infection 
* Lymphadenitis cause swelling of the 
lymph nodes that may occur prior to 
maturation.
* Lymphangitis 
• Inflammation of the lymphatic vessels 
usually after maturation. 
• The affected lymphatic vessel becomes 
distended and tender, and the overlying 
skin becomes erythemous and hot. 
Abscess formation and ulceration of the 
affected lymph nodes occasionally occurs 
during B. malayi infection
Lymphadenitis 
Lymphagitis
*Lymphedema (elephantiasis) 
• It is the enlargement of the limbs. 
• Consistent irritation of lymphatic vessels 
leading to blockages caused by dead adult 
worms, inflammatory fibrosis, or 
granulomatous reactions. 
• Elephantiasis resulting from B. 
malayi infection typically affects the lower 
extremities of the legs and arms.
* Secondary bacteria infections 
• lymph node failure caused by extended 
overstimulation
Diagnosis 
• The standard method for diagnosing active 
infection is the identification of microfilariae 
in a blood smear by microscopic examination. 
• The microfilariae that cause lymphatic 
filariasis circulate in the blood at night (called 
nocturnal periodicity). 
• Blood collection should be done at night to 
coincide with the appearance of the 
microfilariae, and a thick smear should be 
made and stained with Giemsa or hematoxylin 
and eosin.
• Serologic techniques provide an 
alternative to microscopic detection of 
microfilariae for the diagnosis of 
lymphatic filariasis. 
• Patients with active filarial infection 
typically have elevated levels of 
antifilarial IgG4 in the blood and these 
can be detected using routine assays.
Treatment 
• Diethylcarbamazine (DEC)- is the drug of 
choice 
• Doxycycline (200mg/day for 4-6 weeks). 
• In patients with Elephantiasis, surgical 
procedures are required as chemotheraphy 
cannot reverse the fibrotic changes. 
• Levamisole hydrochloride- also been used for 
the treatment of W. bancrofti, B. malayi and 
tropical pulmonary eosinophilia. 
• Ivermectin- shown great promise in the 
treatment of filariasis and eosinophic-lung.
Prevention and Control 
The best way to prevent lymphatic filariasis is to 
avoid mosquito bites. 
The mosquitoes that carry the microscopic worms 
usually bite between the hours of dusk and dawn. 
If you live in an area with lymphatic filariasis: 
• at night 
– sleep in an air-conditioned room or 
– sleep under a mosquito net 
• between dusk and dawn 
– wear long sleeves and trousers and 
– use mosquito repellent on exposed skin.
The end 
Brugia malayi

Brugia malayi

  • 1.
  • 2.
    Scientific classification Kingdom:Animalia Phylum: Nematoda Class: Secernentea Order: Spirurida Family: Filariidae Genus: Brugia Species: B. malayi
  • 3.
    Brugia malayi •is a roundworm nematode, one of the three causative agents of lymphatic filariasis in humans. • Lymphatic filariasis, also known as elephantiasis, is a condition characterized by swelling of the lower limbs. • The two other filarial causes of lymphatic filariasis areWuchereria bancrofti and Brugia timori, which differ from Brugia malayi morphologically, symptomatically, and in geographical extent
  • 4.
    Geographical distribution •B. malayi infects 13 million people in south and southeast Asia and is responsible for nearly 10% of the world’s total cases of lymphatic filariasis • B. malayi infection is endemic or potentially endemic in 16 countries, where it is most common in southern China and India, but also occurs in Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and South Korea
  • 6.
    Morphology • Femaleadult worms measures between 43-55 mm in length by 130-170 um in width. • Male adult worms measures between 13- 23 mm in length by 70-80 um in width.
  • 7.
    Microfilariae • B.malayi microfilariae measures 177-230 um in length and 5-7 um in width and have a round anterior end and a pointed posterior end. • The sheath is actually the egg shell, a thin layer that surrounds the egg shell as the microfilariae circulates in the bloodstream. • The microfilariae retain the sheath until it is digested in the mosquito midgut
  • 8.
    Adult Sections ofadult Brugia sp. From a lymph node, stained with hematoxylin and eosin. Microfilariae Posterior end of B. malayi microfilariae – note the two distinctive terminal nuclei
  • 10.
    Life Cycle •The typical vector for Brugia malayi filariasis are mosquito species from genera Mansonia and Aedes.
  • 11.
  • 12.
    Symptoms • AsymptomaticPhase: Upon initial infection no symptoms may be present as microfilariae mature. • B. Malayi is one of the causative agents of lymphatic filariasis, a condition marked by infection and swelling of the lymphatic system. • The disease is primarily caused by the presence of worms in the lymphatic vessels and the resulting host response.
  • 13.
    • Signs ofinfection are typically consistent with those seen in bancroftian filariasis – fever, lymphadenitis, lymphangitis, lymphedema, and secondary bacterial infection * Lymphadenitis cause swelling of the lymph nodes that may occur prior to maturation.
  • 14.
    * Lymphangitis •Inflammation of the lymphatic vessels usually after maturation. • The affected lymphatic vessel becomes distended and tender, and the overlying skin becomes erythemous and hot. Abscess formation and ulceration of the affected lymph nodes occasionally occurs during B. malayi infection
  • 15.
  • 16.
    *Lymphedema (elephantiasis) •It is the enlargement of the limbs. • Consistent irritation of lymphatic vessels leading to blockages caused by dead adult worms, inflammatory fibrosis, or granulomatous reactions. • Elephantiasis resulting from B. malayi infection typically affects the lower extremities of the legs and arms.
  • 18.
    * Secondary bacteriainfections • lymph node failure caused by extended overstimulation
  • 19.
    Diagnosis • Thestandard method for diagnosing active infection is the identification of microfilariae in a blood smear by microscopic examination. • The microfilariae that cause lymphatic filariasis circulate in the blood at night (called nocturnal periodicity). • Blood collection should be done at night to coincide with the appearance of the microfilariae, and a thick smear should be made and stained with Giemsa or hematoxylin and eosin.
  • 20.
    • Serologic techniquesprovide an alternative to microscopic detection of microfilariae for the diagnosis of lymphatic filariasis. • Patients with active filarial infection typically have elevated levels of antifilarial IgG4 in the blood and these can be detected using routine assays.
  • 21.
    Treatment • Diethylcarbamazine(DEC)- is the drug of choice • Doxycycline (200mg/day for 4-6 weeks). • In patients with Elephantiasis, surgical procedures are required as chemotheraphy cannot reverse the fibrotic changes. • Levamisole hydrochloride- also been used for the treatment of W. bancrofti, B. malayi and tropical pulmonary eosinophilia. • Ivermectin- shown great promise in the treatment of filariasis and eosinophic-lung.
  • 22.
    Prevention and Control The best way to prevent lymphatic filariasis is to avoid mosquito bites. The mosquitoes that carry the microscopic worms usually bite between the hours of dusk and dawn. If you live in an area with lymphatic filariasis: • at night – sleep in an air-conditioned room or – sleep under a mosquito net • between dusk and dawn – wear long sleeves and trousers and – use mosquito repellent on exposed skin.
  • 23.